Edwards Lifesciences Corporation: The story continues

Edwards Lifesciences operates in four divisions, but the main one, Transcatheter Aortic Valve Replacement (TAVR), accounts for 64.6% of sales. Cardiac surgery equipment accounts for 16.6% of the total. The Transcatheter Technology business (TMTT) is the smallest (just 3.3% of revenues), but the fast…
© MarketScreener.com 2024